# VYXARA — Api18/Hera T2I registry proposal acceptance evidence (lab-only)

Review date: 2026-09-05
Scope: controlled VYXARA local/test activation proposal only
Human decision supported: `approved`
Production approval: NO
Registry application: NO
Execution/network/spend authorization: NO

## Exact proposal under review

Proposal SHA-256:
`9857ae0d81d294145a44d6f79ba337288ccd4fb7b70857dd110bc9117c7502ef`

Source review decisions:
- policy: `b9ba8e11-1fde-4b46-87a1-d67e2c6fede5`
- commercial: `4e56ab26-859d-4987-a508-669e2ba682d8`
- activation: `c54cf70a-f338-4d1f-9438-8e9978fe2b6c`
- Hera T2I release: `ce9856cc-afaf-4867-ade6-44a7efc6ab0c`

## Reviewed deterministic delta

Provider Api18, current -> proposed:
- integration: `candidate` -> `approved`
- policy: `review_required` -> `approved`
- commercial: `review_required` -> `approved`
- allowed environments: `[]` -> `[local]`
- kill switch: `ON` -> `OFF`

Hera 1.0 Text-to-Image, current -> proposed:
- lifecycle: `candidate` -> `approved`
- allowed environments: `[]` -> `[local]`
- kill switch: `ON` -> `OFF`
- production remains `OFF`

The VYXARA control plane reported the proposal contract valid and reported no registry mutation, execution authorization, network authorization, spend authorization, or production inclusion while generating this preview.

## Lab-only acceptance conclusion

The exact proposal SHA above is accepted as the reviewed deterministic local/test registry-change proposal for the first controlled Api18/Hera T2I validation sequence.

This acceptance does not itself apply the registry patch, reload a running service, provision a provider credential, release execution/network/spend controls, call Api18, spend funds, or enable production.

Recommended acceptance record:
- decision: `approved`
- reasonCode: `lab_registry_proposal_hash_accepted`
- validUntil: `2026-11-30T11:59:00-05:00`
